FDA official says COVID-19 vaccines for children under age 12 expected to be approved in winter 

BREAKING NEWS: FDA official says COVID-19 vaccines for children under age 12 is expected to be approved for emergency use in winter

  • FDA official said approval of COVID-19 vaccines in children under age 12 is expected in early or midwinter
  • After the the shots are given emergency use authorization for kids, the agency hopes to quickly give the shots full approval
  • Pfizer and Moderna are both conducting clinical trials in younger children 

An official from the U.S. Food and Drug Administration (FDA) says COVID-19 vaccines for children under age 12 are expected to be approved in early or midwinter.

First reported by NBC News, it could mean that youngsters are vaccinated over Christmas break before heading back to school for the spring semester.

The official said that after the the shots are given emergency use authorization for kids, the agency hopes to quickly give the shots full approval. 

Parents and doctors are split over whether or not to vaccinate children because they make up less 0.1 percent of all COVID-19 deaths.

FDA official said approval of COVID-19 vaccines in children under age 12 is expected in early or midwinter. Pictured: Caleb Chung receives the first dose of Pfizer coronavirus vaccine or placebo as a trial participant for kids ages 12 to 15, December 2020

This is a breaking news story and will be updated. 

Read more at DailyMail.co.uk